2-{[3-cyano-6-(3-methoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}-N-(1,3,4-thiadiazol-2-yl)acetamide

Catalog No. :
ACRLMZ245
CAS No. :
625378-18-9
Molecular Formula :
C18H12F3N5O2S2
Molecular Weight :
451.45

IUPAC Name:2-((3-cyano-6-(3-methoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl)thio)-N-(1,3,4-thiadiazol-2-yl)acetamide

2-{[3-cyano-6-(3-methoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}-N-(1,3,4-thiadiazol-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$321.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[3-cyano-6-(3-methoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}-N-(1,3,4-thiadiazol-2-yl)acetamide
IUPAC Name2-((3-cyano-6-(3-methoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl)thio)-N-(1,3,4-thiadiazol-2-yl)acetamide
Molecular FormulaC18H12F3N5O2S2
Molecular Weight451.45
SMILESO=C(NC1=NN=CS1)CSC2=NC(C3=CC=CC(OC)=C3)=CC(C(F)(F)F)=C2C#N
InChI KeyLLRPUJVHPLXYKI-UHFFFAOYSA-N
Synonym2-{[3-cyano-6-(3-methoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}-N-(1,3,4-thiadiazol-2-yl)acetamide;Acetamide, 2-[[3-cyano-6-(3-methoxyphenyl)-4-(trifluoromethyl)-2-pyridinyl]thio]-N-1,3,4-thiadiazol-2-yl-
CAS No.625378-18-9

Synthetic Route by SureRoute

1. ACRLMZ245 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKOTL573 route compound structure diagram
    ACKOTL5734005-51-0 In Stock
  4. Then
  5. ACRLMZ245 route product structure diagram
    ACRLMZ245625378-18-9
Inquiry

2. ACRLMZ245 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRLMZ245 route product structure diagram
    ACRLMZ245625378-18-9
Inquiry

Comments (0)